Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at how INC280 affects caffeine and midazolam in people with solid tumours

Overview

Cancer types:

All cancer types

Status:

Closed

Phase:

Phase 1

Details

A trial for people with solid tumours that have spread () and that have a change on the cMET gene. A is any type of cancer apart from those of the blood or lymphatic system such as or .

This trial is looking at how a drug called INC280 changes the way caffeine and midazolam are broken down by the body.

Recruitment start: 16 June 2016

Recruitment end: 22 November 2016

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Moditha Nawinne

Supported by

Novartis

Last reviewed: 21 June 2016

CRUK internal database number: 14111

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.